NVAX Jan 2025 40.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:23PM EDT
| Previous close | 0.8200 |
| Open | 0.8000 |
| Bid | 0.8400 |
| Ask | 1.1900 |
| Strike | 40.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.8000 - 0.8600 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.37k |
PR NewswireNovavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
ZacksHere is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Barrons.comArbutus, Novavax See Activist Investor Action
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
© 2024 Yahoo. All rights reserved.